Bishoy M. Faltas, M.D.
< Back to Search Results

Bishoy M. Faltas, M.D.


Profile Photo of Bishoy M. Faltas, M.D.
Accepts New Patients
Gender: Male
Language: English


Personal Statement

My philosophy is simple: the patient comes first. As part of the Genitourinary Oncology Program at Weill Cornell Medicine, I am committed to delivering the best care to my patients. Our world-class multidisciplinary team ensures that we treat the patient as a whole, not just the cancer. I am driven by the desire to improve therapy of urological malignancies by identifying the genetic “Achilles heel” of each patient’s cancer. Through my research, I am committed to developing “precision medicine” approaches and conducting clinical trials for treatment of bladder cancer and other genitourinary malignancies. 

Specialties and Expertise


  • Urological Oncology


  • Bladder Cancer
  • Cancer of Ureter
  • Urethral Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Immunotherapy
  • Genomics


Dr. Bishoy Morris Faltas is an Assistant Professor of Medicine at Weill Cornell Medicine and an Assistant Attending in the Genitourinary Oncology Program in the Division of Hematology & Medical Oncology. 

Dr. Faltas completed his Hematology and Medical Oncology Fellowship at Weill Cornell Medicine, as well as additional training through a research fellowship in the laboratory of Dr. Mark A. Rubin. During this time, he led studies of the clonal evolution and the neoantigenic structure of platinum-resistant bladder cancer. As a physician-scientist, Dr. Faltas conducts research focusing on understanding the molecular profiles of metastatic platinum-resistant urothelial bladder cancer. His research focus is on the mechanisms of mutagenesis and drug-resistance in bladder carcinoma, as well as immunogenomic studies of urological malignancies. By understanding the molecular changes that occur as urothelial cancer evolves under the effect of chemotherapy and metastatic spread, Dr. Faltas aims to identify potential drug targets for translation into therapeutic clinical trials. He is an active member of the The Caryl and Israel Englander Institute for Precision Medicine focusing on the application of genomic approaches to clinical trials by tailoring treatment based on the unique molecular profile of each patient’s cancer. 

Dr. Faltas is the recipient of several research awards, including the Scott-Wadler Fellow Research award and the Weill Department of Medicine Fellow Award in Research. He has also received the NIH/NCATS CTSC KL2 Scholar grant, the American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award and the Department of Defense Career Development Award.

Dr. Faltas has published several articles in peer-reviewed journals such as the Nature Genetics, New England Journal of Medicine, JAMA Oncology, Journal of Clinical Oncology. Additionally, he is a reviewer for several journals including Nature Communications, American Journal of Medicine, Science Translational Medicine, and Nature Scientific Reports. Dr. Faltas is a member of the editorial board of the ASCO Post. He also served as an Associate Scientific Advisor for the journal Science Translational Medicine.


Honors and Awards

Honors and Awards

American Association for Cancer Research(AACR) NextGen Star (2017)

Finalist, best research presentation, Immuno-oncology Young Investigators’ forum (2016)

American Society of Clinical Oncology (ASCO) Merit Award to present at the 2016 ASCO annual Genitourinary symposium (2016)

2014-2015 Scott Wadler Memorial Fellow Clinical Research Award (2015)

1st place in Department of Medicine Fellows Research Award competition, Weill Cornell Medical College (2015)

American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation Young Investigator Award (2015)

American Society of Clinical Oncology (ASCO) Merit Award to present at the 2015 ASCO annual meeting (2015)

American Society of Clinical Oncology (ASCO) Merit Award to present at the 2015 ASCO annual Genitourinary symposium (2015)

2013-2014 Scott Wadler Memorial Fellow Clinical Research Award (2014)

Award to attend the Annual AACR Workshop: Molecular Biology in Clinical Oncology (2014)

Award to attend the Cancer Education Consortium Molecular and Translational Oncology Workshop (2014)

Scholarship to attend ASCO-AACR Methods in Clinical Oncology Workshop (2013)

American Medical Association (AMA) Policy Promotion Grant (2009)


Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine (Medical Oncology)

Clinical and Academic Positions

  • Assistant Attending Physician - NewYork-Presbyterian Hospital
  • Assistant Professor of Medicine - Weill Cornell Medical College, Cornell University
  • Assistant Professor of Cell and Developmental Biology - Weill Cornell Medical College, Cornell University
  • Gellert Family-John P. Leonard, M.D. Research Scholar - Weill Cornell Medical College, Cornell University

Education and Training

  • M.B.,B.Ch., College of Medicine Assiut (Egypt), 2004


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna Weill Cornell Employee Managed Care Plan
  • Aetna Weill Cornell Employee PPO Plan
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • AgeWell New York
  • Amida Care
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Medicaid
  • Medicare
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare - Medicare
  • United Healthcare Compass
  • VNSNY CHOICE - Medicare
  • WellCare of NY
  • WorldWide Medical

Locations and Appointments

News and Media

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member:
Immunomedics, Inc.; Seattle Genetics, Inc.; Springer Publishing Company
Astrin Biosciences, Inc.; BostonGene
Other Interest:
BostonGene; Gilead Sciences, Inc.; Guardant Health, Inc.; Merck & Co., Inc.; Natera, Inc.
Professional Services: